Featured Jobs
|
Regional Vice President, Sales MAP Retirement
|
|
3(16) Retirement Plan & Customer Liaison Compass
|
|
DWC - The 401(k) Experts
|
|
Pattison Pension
|
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
|
Retirement Relationship Manager MAP Retirement
|
|
MAP Retirement
|
|
MAP Retirement
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
|
Sentinel Group
|
|
Pension Investors Corporation
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations
The Peterson-Kaiser Health System Tracker 
Aug. 15, 2024 "Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million people used at least one of the ten drugs that have been identified for Medicare price negotiations.... The most common was Jardiance, a drug used to treat diabetes and heart failure, with over 911,000 enrollees; the least common was Imbruvica, a drug used to treat blood cancers, with only 5,000 enrollees." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |